Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany.
Andreas Adler, Sebastian Geiger, Anne Keil...
https://pubmed.ncbi.nlm.nih.gov/25326034Actively Recruiting
Phase Not Applicable
Age: 50Years - 69Years
All Genders
Healthy Volunteers
ID06696534
Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
Led by ADVANCED MARKER DISCOVERY S.L. · Updated on 2025-10-02
1000
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
Sponsors
A
ADVANCED MARKER DISCOVERY S.L.
Lead Sponsor
S
SERMAS
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying how participants feel about and prefer different screening methods in a colorectal cancer screening program. This low-risk interventional study focuses on adults aged 50 to 69 years who are asymptomatic and part of a population-based screening program. The main goal is to understand participants' experiences and preferences after undergoing fecal occult blood test (FOBT) screening. Participants will complete two questionnaires: one about their preference for colorectal cancer screening methods and another about their experience in the screening program. These surveys will be conducted within the colorectal cancer screening program involving average-risk individuals undergoing fecal immunochemical test (FIT) or FOBT. During the study, participants will provide information through these questionnaires, and their clinical data will be shared with investigators or health personnel. The primary outcome is the value of the questionnaires related to the screening program, assessed over 12 months. Participants will be monitored for their responses and experiences during this period, with no additional interventions or treatments involved.
CONDITIONS
Brief Title
Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
Who Can Participate
Age: 50Years - 69Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Participants ages from 50 to 69 years at the time of informed consent.
- Participants invited to take part in a population-based colorectal cancer screening program eligible for FOBT at the Primary Health Care Center.
- Participants must sign informed consent after understanding the study's nature and risks.
You will not qualify if you...
- Participants who have not delivered a stool sample at the Primary Health Care Center before signing informed consent.
- Participants with a previous colonoscopy following a positive FOBT result.
- Participants in a dependent personal or non-medical relationship with the study sponsor or investigators.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surveillance
Duration - 12 months
Participants complete questionnaires to share their preferences and experiences regarding colorectal cancer screening methods.
1 to 2 visits depending on questionnaire completion
Trial Site Locations
Total: 2 locations
1
UCSP Sete Rios
Lisbon, Portugal
Not Yet Recruiting
2
CS Mar Báltico
Madrid, Madrid, Spain
Actively Recruiting
Loading map...
Research Team
M
Marta Jimenez, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.
Roberta De Angelis, Elena Demuru, Paolo Baili...
https://pubmed.ncbi.nlm.nih.gov/38307102Colorectal cancer statistics, 2023.
Rebecca L Siegel, Nikita Sandeep Wagle, Andrea Cercek...
https://pubmed.ncbi.nlm.nih.gov/36856579